What is ADIL's earnings growth forecast for 2025-2025?
(NASDAQ: ADIL) Adial Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.
Adial Pharmaceuticals's earnings in 2025 is -$8,449,950.
In 2025, ADIL is forecast to generate -$12,005,518 in earnings, with the lowest earnings forecast at -$12,005,518 and the highest earnings forecast at -$12,005,518.
What is ADIL's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: ADIL) forecast ROE is N/A, which is considered weak.
What is ADIL's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ADIL) Adial Pharmaceuticals's current Earnings Per Share (EPS) is -$1.05. In 2025, ADIL's EPS is forecast to hit -$0.55 (min: -$0.55, max: -$0.55).
What is ADIL's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: ADIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 47.5%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.